Literature DB >> 1331157

Cloning and expression of a cDNA encoding the Epstein-Barr virus thymidine kinase gene.

M Y Liu1, C Y Pai, S M Shieh, T Y Hsu, J Y Chen, C S Yang.   

Abstract

A clone of the Epstein-Barr virus (EBV) thymidine kinase (TK) gene was derived from a cDNA library of P3HR1 cells. The gene product was expressed as a fusion protein in a procaryotic system by using T7 RNA polymerase. The recombinant TK showed a molecular mass of 67 kDa and was biologically active. Antiserum raised in mice immunized with partially purified TK recognized an antigen present in EBV-superinfected Raji cells using an indirect immunofluorescence assay.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331157     DOI: 10.1016/0166-0934(92)90012-3

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  5 in total

1.  Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues.

Authors:  S M Moore; J S Cannon; Y C Tanhehco; F M Hamzeh; R F Ambinder
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

2.  Anti-Epstein-Barr virus (EBV) activity of beta-L-5-iododioxolane uracil is dependent on EBV thymidine kinase.

Authors:  T Kira; S P Grill; G E Dutschman; J S Lin; F Qu; Y Choi; C K Chu; Y C Cheng
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

3.  The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase.

Authors:  E A Gustafson; A C Chillemi; D R Sage; J D Fingeroth
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

4.  Identification and characterization of the conserved nucleoside-binding sites in the Epstein-Barr virus thymidine kinase.

Authors:  Chung-Chun Wu; Min-Che Chen; Ya-Ru Chang; Tsuey-Ying Hsu; Jen-Yang Chen
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

Review 5.  The antiviral prophylaxis of post-transplant lymphoproliferative disorder.

Authors:  C L Davis
Journal:  Springer Semin Immunopathol       Date:  1998
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.